Lymphangiogenesis in malignant tumours: does it occur?

被引:84
作者
Clarijs, R [1 ]
Ruiter, DJ [1 ]
de Waal, RMW [1 ]
机构
[1] Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands
关键词
VEGFR-3; flt-4; VEGF-C; lymphangiogenesis; angiogenesis; carcinoma;
D O I
10.1002/path.808
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The development of a vascular bed is essential for solid tumour growth and metastasis, In many rumours, mean vascular density can be related to the rate of metastasis and, therefore, to prognosis. In other tumour types, such as cutaneous melanoma and head-and-neck squamous cell carcinoma, this relation is absent. Until now, the reason for this has been unclear, but since these particular tumour types are also known for their propensity to spread via the lymphatic system, it may be speculated that the presence of a pre-existing lymphatic bed and the formation of new lymphatics (lymphangiogenesis) are important factors, Growth factors involved in lymphangiogenesis during embryogenesis have been recently identified and these are also expressed in many tumour types, but the existence of tumour-induced lymphangiogenesis has not so far been reported. Partly, this could be due to the lack of reliable endothelial markers, thereby hampering a consistent evaluation of lymphatic vasculature, This editorial discusses the role of the lymphatic bed in mediating the metastasis of solid rumours, summarizes known methods to detect lymphatics, and proposes a hypothetical mechanism of tumour-induced lymphangiogenesis, Copyright (C) 2000 John Wiley & Sons, Ltd.
引用
收藏
页码:143 / 146
页数:4
相关论文
共 50 条
  • [1] Achen MG, 2001, J PATHOL, V193, P147, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO
  • [2] 2-G
  • [3] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
    Achen, MG
    Jeltsch, M
    Kukk, E
    Mäkinen, T
    Vitali, A
    Wilks, AF
    Alitalo, K
    Stacker, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 548 - 553
  • [4] André T, 2000, INT J CANCER, V86, P174, DOI 10.1002/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.3.CO
  • [5] 2-5
  • [6] Thrombomodulin as a marker of vascular and lymphatic tumours
    Appleton, MAC
    Attanoos, RL
    Jasani, B
    [J]. HISTOPATHOLOGY, 1996, 29 (02) : 153 - 157
  • [7] TUMOR VASCULARITY IS NOT A PROGNOSTIC FACTOR FOR CUTANEOUS MELANOMA
    BARNHILL, RL
    BUSAM, KJ
    BERWICK, M
    BLESSING, K
    COCHRAN, AJ
    ELDER, DE
    FANDREY, K
    KARAOLI, T
    WHITE, WL
    [J]. LANCET, 1994, 344 (8931) : 1237 - 1238
  • [8] Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries -: Podoplanin as a specific marker for lymphatic endothelium
    Breiteneder-Geleff, S
    Soleiman, A
    Kowalski, H
    Horvat, R
    Amann, G
    Kriehuber, E
    Diem, K
    Weninger, W
    Tschachler, E
    Alitalo, K
    Kerjaschki, D
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02) : 385 - 394
  • [9] BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141
  • [10] Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
    Bunone, G
    Vigneri, P
    Mariani, L
    Butó, S
    Collini, P
    Pilotti, S
    Pierotti, MA
    Bongarzone, I
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) : 1967 - 1976